ArticleTheranostics2020

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.

Shuli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.